Tatva Chintan Pharma Chem Ltd

BSE
TATVA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Tatva Chintan Pharma Chem Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
37.68% Fall from 52W High
-10.5
TTM PE Ratio
High in industry
88.8
Price to Book Ratio
Below industry Median
3.7
Dividend yield 1yr %
Low in industry
0.2
TTM PEG Ratio
PEG TTM is negative
-2.7
RSI
RSI is mid-range
58.2
MFI
MFI is mid-range
64.4

Tatva Chintan Pharma Chem Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Tatva Chintan Pharma Chem Ltd shareholding Pattern

Promoter
72%
Foreign Institutions
3.4%
Mutual Funds
10.6%
Domestic Institutions
10.6%
Public
14%
Promoter
72%
Foreign Institutions
3.6%
Mutual Funds
12.8%
Domestic Institutions
12.8%
Public
11.5%
Promoter
72%
Foreign Institutions
4.2%
Mutual Funds
13%
Domestic Institutions
13.1%
Public
10.7%
Promoter
72%
Foreign Institutions
4.4%
Mutual Funds
13.5%
Domestic Institutions
13.8%
Public
9.8%
Promoter
79.2%
Foreign Institutions
3.2%
Mutual Funds
10.8%
Domestic Institutions
11.1%
Public
6.6%
Promoter
79.2%
Foreign Institutions
3.5%
Mutual Funds
11%
Domestic Institutions
11.7%
Public
5.6%

Tatva Chintan Pharma Chem Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
1,155.20
10Day EMA
1,147.70
12Day EMA
1,143.60
20Day EMA
1,129.30
26Day EMA
1,123.50
50Day EMA
1,127.70
100Day EMA
1,183.50
200Day EMA
1,317.20
5Day SMA
1,159.00
10Day SMA
1,152.50
20Day SMA
1,127.00
30Day SMA
1,088.50
50Day SMA
1,103.30
100Day SMA
1,159.80
150Day SMA
1,264.10
200Day SMA
1,328.60
Delivery & Volume
Resistance & Support
1,159.35
Pivot
Resistance
First Resistance
1,168.70
Second Resistance
1,184.55
Third Resistance
1,193.90
Support
First Support
1,143.50
Second support
1,134.15
Third Support
1,118.30
Relative Strength Index
58.24
Money Flow Index
64.39
MACD
20.06
MACD Signal
15.97
Average True Range
38.66
Average Directional Index
41.50
Rate of Change (21)
13.18
Rate of Change (125)
-23.96
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bhansali Engineering Polymers Ltd.
3573.61
81.72
164.5
Jubilant Industries Ltd.
2301.35
496.7
1787
Vishnu Chemicals Ltd.
2859.93
247.95
482.55
Vidhi Specialty Food Ingredients Ltd.
2144.64
338
496.4
Tinna Rubber and Infrastructure Ltd.
-
-
-
Yasho Industries Ltd.
-
-
-

Tatva Chintan Pharma Chem Ltd Company background

Founded in: 1996
The Company was formerly incorporated as Tatva Chintan Pharma Chem Private Limited in India on 12 June 1996 under the Companies Act 2013. The status of the Company got converted from Private Limited into a Public Limited Company effective from 27 January 2021 and consequently, the name of Company also changed from Tatva Chintan Pharma Chem Private Limited to Tatva Chintan Pharma Chem Limited. The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is primarily engaged in manufacturing and selling of specialty chemicals, Pharma Agro intermediates and Quaternary Ammonium Compounds (Quats). The Company is a globally recognized specialty chemical player with several market leading products in its portfolio. Considering the wide application of products, the Company supply products to leading global companies across diverse industries, like automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care and flavor and fragrances with over 1300 customers. Apart from customers in India, the Company export products across the globe including USA, China, Germany, Japan, South Africa and UK. The Company operate through two world class manufacturing facilities located at Dahej and Ankleshwar in Gujarat both of which are strategically located very close to the Hazira Port. These units provide the Company cost and logistics advantage and enabling seamless export and import operations. The Companys manufacturing facilities obtained ISO 9001:2015 and 14001:2015 certification for robust quality management systems. Employing modern equipment like reactors, assembly lines, ANFDs, centrifuges and RCVDs, enabled the Company to undertake multiple chemistry process. The Company successfully established an integrated model comprising world class manufacturing infrastructure, complex chemical processes, warehousing facilities and technically sound RD capabilities, which enables to achieve high operational efficiency and quality, to innovate customize and to ensure sustainable operations with wide offerings. The Company has sophisticated quality control lab equipped with modern analytical equipment, enabling it to detect impurities upto PPM levels and achieve ultrapuregrade certification. The Company Promoters identified an opportunity in manufacturing Phase Transfer Catalyst (PTC), which is a niche segment within the specialty chemicals space. With PTC as the base, the Company have marked presence in the entire value chain including PTC, Structure Directing Agents (SDA), Electrolyte Salts (ES) and Pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC).The Company have a dedicated Department of Scientific and Industrial Research (DSIR) approved RD centre at its Vadodara facility where qualified and experienced inhouse RD team focus on development of new products and improvement in current manufacturing processes. The Company is having modern systems and analytical development laboratory with stateoftheart instrumentation.In 2004, the Company received licence from the FDA, Gujarat at its Ankleshwar manufacturing plant.In 2007, the Company commenced Ankleshwar manufacturing facility and increased the expansion of manufacturing capacity.In 2011, the Company started commercial manufacturing of Structure Directing Agents (SDA).In 2015, the Company was accredited Appreciation Certificate for the Ankleshwar Plant from the Office of the Chief Commission of Central Excise, Customs Service Tax, Vadodara Zone for its contribution to revenue and voluntary compliance with tax laws. The Company achieved revenue of nearly Rs 1 bn. The Company established a warehousing plant in The Netherlands. Tatva Chintan USA Inc. was incorporated as a wholly owned Subsidiary of TCPCL.In 2016, the Company was accorded the status of a twostar export house for the Ankleshwar plant from the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry (MoCI), Government of India (GoI).In 2017, manufacturing plant was established in Dahej, Gujarat. In 2018, the RD facility was set up in Vadodara.Tatva Chintan Europe BV, was incorporated as wholly owned Subsidiary of the Company in year 2019.In FY 201920, the Companys Ankleshwar unit was converted to a zero liquid effluent discharge facility. The products proved efficiency to ensure lower byproducts and waste generation in chemical processes.Additionally, the Company participated in the Together for Sustainability initiatives whereby sustainability sourcing practices of chemical suppliers, like ecological and social aspects were assessed. Under this initiative, the Company involved Ecovadis to audit sustainability practices and performance, the results of which were above the industry average. This created a robust initiative and focused on retaining key customers who consider sustainability an important parameter to do business. In 2020, the Company achieved another Rs 2 billion revenue.In 2021, the manufacturing capacity at Dahej facility in Gujarat increased giving rise to aggregate installed reactor manufacturing capacity of the Company from 160 KL and 10 Assembly Lines to 280 KL and 17 Assembly Lines respectively.During the year 2021, the Company had issued 12,052,500 Equity Shares as Bonus Shares to all the existing shareholders of the Company in the ratio of 1.5:1 vide Board Resolution dated 03 March 2021 which was passed pursuant to passing of Special Resolution by Shareholders in ExtraOrdinary General Meeting held on 27 January 2021 against existing 8,035,000 Equity Shares.
Read More

Tatva Chintan Pharma Chem Ltd FAQs

The past 1-year return of Tatva Chintan Pharma Chem Ltd [TATVA] share was -34.47. The Tatva Chintan Pharma Chem Ltd [TATVA] share hit a 1-year low of Rs. 958.15 and a 1-year high of Rs. 1771.

The Mutual Fund Shareholding was 10.6% at the end of .

You can easily buy Tatva Chintan Pharma Chem Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -